Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)
| Autor: | Salar, Antonio *, Avivi, Irit *, Larouche, Jean-Francois *, Janikova, Andrea *, Pereira, Juliana *, Brewster, Mike *, Catalani, Olivier *, McIntyre, Christine *, Sayyed, Pakeeza *, Haynes, Andrew * |
|---|---|
| Zdroj: | In Blood 16 November 2012 120(21):1641-1641 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|